πŸ‡ΊπŸ‡Έ FDA
Patent

US 8080572

Dual-acting antihypertensive agents

granted A61KA61K31/4196A61K45/06

Quick answer

US patent 8080572 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/4196, A61K45/06, A61P, A61P13/12